Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Allurion Technologies, Inc. (ALUR) a Massachusetts-based medical device company Tuesday announced the issuance of a new U.S. patent ...

Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.

thanks to advancements in medical technology. The Allurion intragastric balloon (IGB) is inserted through the mouth into the patient's stomach endoscopically before being expanded with 550 milliliters ...

“Data from the AUDACITY trial demonstrate the Allurion Balloon’s positive impact on weight loss and excellent safety record,” said Dr. Ram Chuttani, Chief Medical Officer and Founding ...

(RTTNews) - Allurion Technologies, Inc. (ALUR) a Massachusetts-based medical device company Tuesday ... This patent covers next-generation balloon technology with enhanced valve precision.

“If approved, the Allurion Balloon could fill a significant gap ... additional trial data will be presented at a future medical meeting. The Company plans to submit the fourth and final module ...

Dr. Shelby Sullivan, Lead Investigator of the AUDACITY trial, expressed confidence in the Allurion Balloon's favorable benefit-risk profile for obesity treatment. Dr. Ram Chuttani, Chief Medical ...